{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T03:29:44Z","timestamp":1668569384351},"reference-count":31,"publisher":"Georg Thieme Verlag KG","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Glaukom ist in Deutschland die zweith\u00e4ufigste Ursache irreversibler Erblindungen. Es stehen verschiedene therapeutische Ans\u00e4tze zur Verf\u00fcgung. Neben der Verbesserung der vaskul\u00e4ren Perfusion und der Reduktion des oxidativen Stresses steht als zentrale Therapieoption nach wie vor die Senkung des Augeninnendrucks im Vordergrund. Daf\u00fcr kommen verschiedene Wirkstoffklassen mit unterschiedlichem Wirkmechanismus und Nebenwirkungsprofil zur Anwendung.<\/jats:p>","DOI":"10.1055\/a-1229-1390","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T22:47:04Z","timestamp":1597099624000},"page":"1241-1258","source":"Crossref","is-referenced-by-count":1,"title":["Medikament\u00f6se Therapie des Glaukoms"],"prefix":"10.1055","volume":"237","author":[{"given":"Elnaz","family":"Emrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","article-title":"Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey","volume":"109","author":"A Sommer","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/archopht.1976.03910040146002","article-title":"Prognostic factors in glaucomatous visual field loss","volume":"94","author":"M A Kass","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"ref3","first-page":"493","article-title":"Zehn Gebote zur medikament\u00f6sen Glaukomtherapie","volume":"30","author":"G Kriegelstein","year":"2009","journal-title":"Z Prakt Augenheilkunde"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/archopht.1960.01840010496004","article-title":"The significance of the diurnal tension variations in normal and glaucomatous eyes","volume":"64","author":"S M Drance","year":"1960","journal-title":"Arch Ophthalmol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","article-title":"Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma","volume":"9","author":"S Asrani","year":"2000","journal-title":"J Glaucoma"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1442-9071.2010.02455.x","article-title":"Vascular Risk Factors in Glaucoma: A Review","volume":"39","author":"M Yanagi","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"ref7","first-page":"159","volume-title":"BCSC Basic and Clinical Science Course: Glaucoma 2014 \u2013 2015","year":"2014"},{"key":"ref8","volume-title":"Terminology and Guidelines for Glaucoma. 4th ed","author":"European Glaucoma Society","year":"2014"},{"issue":"S 07","key":"ref9","doi-asserted-by":"crossref","first-page":"433s","DOI":"10.1042\/cs061433s","article-title":"Effects of short-term and long-term treatment with cardio-selective and non-selective P-receptor blockade on carbohydrate and lipid metabolism and on plasma catecholamines at rest and during exercise","volume":"61","author":"G Koch","year":"1981","journal-title":"Clin Sci (Lond)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/diacare.14.3.203","article-title":"Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism","volume":"14","author":"H O Lithel","year":"1991","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/jop.1992.8.183","article-title":"Effects of D- and L-isomers of timolol on retinal and choroidal blood flow in ocular hypertensive rabbit eyes","volume":"8","author":"G CY Chio","year":"1992","journal-title":"J Ocular Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/BF02169445","article-title":"Vasoconstrictive effect of topical timolol on human retinal arteries","volume":"227","author":"X D Martin","year":"1989","journal-title":"Graefe\u02bcs Arch Clin Exp Ophthalmol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study","volume":"151","author":"T Krupin","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1167\/iovs.05-1253","article-title":"Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure patients with glaucoma","volume":"47","author":"L Quaranta","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"S 01","key":"ref15","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0039-6257(96)82029-7","article-title":"Clinical experience with brimonidine 0.2\u200a% and timolol 0.5\u200a% in glaucoma and ocular hypertension","volume":"41","author":"J S Schumann","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"ref16","first-page":"2461","article-title":"Prostaglandin effects on isolated rhesus monkey ciliary muscle","volume":"36","author":"J F Poyer","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0002-9394(01)00831-5","article-title":"Potential mechanism for the additivity of pilocarpine and latanoprost","volume":"131","author":"C B Toris","year":"2001","journal-title":"Am J Ophthalmology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0161-6420(01)00584-X","article-title":"Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial","volume":"108","author":"J D Brandt","year":"2001","journal-title":"Ophthalmology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.ijg.0000212214.18018.41","article-title":"An Evaluation of the Rate of Nonresponders to Latanoprost Therapy","volume":"15","author":"L Rossetti","year":"2006","journal-title":"J Glaucoma"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0161-6420(02)01891-2","article-title":"Effect of Bimatoprost on Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Who Are Nonresponders to Latanoprost","volume":"110","author":"S A Gandolfi","year":"2003","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/08820538.2011.588650","article-title":"The Use of Prostaglandin Analogs in the Uveitic Patient","volume":"26","author":"M B Horsley","year":"2011","journal-title":"Semin Ophthalmol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/jop.1996.12.363","article-title":"The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor","volume":"12","author":"M F Sugrue","year":"1996","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"C1057","DOI":"10.1152\/ajpcell.00481.2007","article-title":"Novel molecular insights into RhoA GTPase-induced resistance to aqueous humor outflow through the trabecular meshwork","volume":"295","author":"M Zhang","year":"2008","journal-title":"Am J Physio Cell Physiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exer.2016.08.023","article-title":"Role of the Rho GTPase\/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: bench to bedside research","volume":"158","author":"P V Rao","year":"2017","journal-title":"Exp Eye Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2019.01.003","article-title":"Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)","volume":"200","author":"M Y Kahook","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajo.2019.06.016","article-title":"Netarsudil\/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from Randomized Phase 3\u2009Trial","volume":"207","author":"S Asrani","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1358\/dot.2018.54.8.2849627","article-title":"Netarsudil ophthalmic solution 0.02\u200a% for the treatment of patients with open-angle glaucoma or ocular hypertension","volume":"54","author":"C C Kopczynski","year":"2018","journal-title":"Drugs Today"},{"key":"ref28","first-page":"157","article-title":"[Mitochondrial Dysfunctions and Role of Coenzyme Q10 in Patients with Glaucoma]","volume":"235","author":"C Erb","year":"2018","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.116.07664","article-title":"Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials","volume":"68","author":"X Zhang","year":"2016","journal-title":"Hypertension"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1167\/iovs.03-0567","article-title":"Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures","volume":"45","author":"W A Hare","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ophtha.2018.06.017","article-title":"Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies","volume":"125","author":"R N Weinreb","year":"2018","journal-title":"Ophthalmology"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1229-1390.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T23:51:45Z","timestamp":1602805905000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1229-1390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,15]]},"published-print":{"date-parts":[[2020,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1229-1390","relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]}}}